SS
TXG icon

SBI Securities’s 10x Genomics TXG Stock Holding History

SBI Securities’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Sell
7,528
-6,140
-45% -$161K 0.01% 559
2026
Q1 		$290K Sell
13,668
-979
-7% -$19.6K 0.01% 531
2025
Q4 		$239K Buy
14,647
+2,273
+18% +$34.3K 0.01% 579
2025
Q3 		$145K Buy
12,374
+340
+3% +$4.43K ﹤0.01% 727
2025
Q2 		$139K Sell
12,034
-495
-4% -$4.51K ﹤0.01% 705
2025
Q1 		$109K Buy
12,529
+409
+3% +$5.16K ﹤0.01% 711
2024
Q4 		$174K Buy
+12,120
New +$191K 0.01% 584

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities's TXG Position: Q2 2026 in Review

SBI Securities reduced its 10x Genomics (TXG) stake by 45% in Q2 2026, selling an estimated $161K and leaving 7,528 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #559.

SBI Securities first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $290K in Q1 2026. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • SBI Securities held 7,528 shares of 10x Genomics worth $289K as of Q2 2026.
  • SBI Securities sold 6,140 10x Genomics shares in Q2 2026, an estimated $161K.
  • 10x Genomics made up 0.01% of SBI Securities's portfolio in Q2 2026, its #559 holding.
  • SBI Securities first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's 10x Genomics position peaked at $290K in Q1 2026.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.